Kerri Fitzgerald

DocwireNews

According to a report from the President&rsquo;s Cancer Panel, the HPV vaccine continues to be underused in eligible adolescents, thus reducing the ability to&nbsp;protect against HPV-related cancers&nbsp;such as&nbsp;cervical and&nbsp;oropharyngeal cancer, among others.&nbsp;&ldquo;We have a safe, effective vaccine that protects against a cancer-causing virus, and we applaud the efforts of cancer and immunization leaders joining forces and rising to the challenge of accelerating HPV vaccine uptake,&rdquo; said&nbsp;Barbara&nbsp;Rimer,&nbsp;DrPH, chair&nbsp;of the&nbsp;President&rsquo;s Cancer Panel,&nbsp;in a statement.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
President's Cancer Panel updates its report on <a href="https://twitter.com/hashtag/HPV?src=hash&amp;ref_src=twsrc%5Etfw">#HPV</a> vaccination: "Although vaccine uptake has improved in recent years, the fact remains that less than 50% of boys and girls in the United States are fully vaccinated against HPV" <a href="https://t.co/f2qjoDqDVI">https://t.co/f2qjoDqDVI</a> <a href="https://t.co/zs1s4oxcBD">pic.twitter.com/zs1s4oxcBD</a>
&mdash; NCI Prevention &amp; Early Detection (@NCIprevention) <a href="https://twitter.com/NCIprevention/status/1060245504217485314?ref_src=twsrc%5Etfw">November 7, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>In&nbsp;a 2012-2013 report, the panel&nbsp;called for more widespread uptake of the HPV vaccine among eligible recipients.&nbsp;The percentage of&nbsp;adolescents who have begun receiving the HPV vaccine has increased by&nbsp;5&nbsp;percentage points&nbsp;each year since that recommendation. However, as of 2017, fewer than half&nbsp;of eligible&nbsp;U.S.&nbsp;adolescents&nbsp;were fully vaccinated.<a href="https://twitter.com/NCIBennett/status/1057968777457995778">https://twitter.com/NCIBennett/status/1057968777457995778</a>&nbsp;The Healthy People 2020&nbsp;initiative has a goal to vaccinate&nbsp;80% of adolescents 13 to 15 years&nbsp;old&nbsp;by 2020, and the current stats indicate that this goal is not on track to succeed.&nbsp;<a href="https://twitter.com/CarrascalAlvaro/status/1005431500102348800">https://twitter.com/CarrascalAlvaro/status/1005431500102348800</a>The&nbsp;President&rsquo;s Cancer Panel&nbsp;issued a renewed call to action to&nbsp;increase HPV vaccination rates&nbsp;nationally and internationally, given the findings. The panel recommended that providers&nbsp;work to&nbsp;reduce the number of missed opportunities to recommend and administer the vaccine to eligible adolescents.&nbsp;Instead of&nbsp;discussing&nbsp;the vaccination in an&nbsp;open-ended way, providers&nbsp;should&nbsp;assume&nbsp;that&nbsp;parents are ready to have their child vaccinated and strongly recommend&nbsp;it&nbsp;for both boys and girls in unequivocal language.&nbsp;&nbsp;<a href="https://prescancerpanel.cancer.gov/report/hpvupdate/pdf/PresCancerPanel_HPVUpdate_Nov2018.pdf">Read the full report.</a>&nbsp;<a href="https://proddocwire.wpengine.com/docwire-pick/common-hpv-associated-cancer/">CDC says oropharyngeal cancer is the most common HPV-related cancer.</a>&nbsp;<a href="https://proddocwire.wpengine.com/hematology-oncology/hpv-test-identifies-cervical-precancer-earlier-than-pap/">HPV test identifies cervical precancer earlier than Pap.</a>&nbsp;Source:&nbsp;President&rsquo;s Cancer Panel

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

HPV Vaccination Rates Remain Below Recommended Target, Reducing Cancer Prevention Opportunities

Oncology

According to a report from the President’s Cancer Panel, the HPV vaccine continues to be underused in eligible adolescents, thus reducing the ability to protect against ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe